You are here

Programmatic Reviews

The Programmatic Reviews bring together Cancer Quality Council of Ontario members, CCO’s executive team, senior staff and Ontario clinical leads with local, national and international experts to review an existing or emerging cancer system program. The group analyzes the program’s effectiveness and make recommendations to Cancer Care Ontario on strategic directions and improvements.

Program Information

Drug Funding Sustainability (2015)

Participants

International, pan-Canadian, provincial and local expertise in the area of drug funding

Summary

International speakers from the United Kingdom and Germany, as well as pan-Canadian experts from Ontario and British Columbia

Insights from provincial cancer agencies (or equivalent), assistant deputy ministers of health, clinical experts, academics, and patients and family members

This review was originally intended to focus only on Cancer Care Ontario’s Provincial Drug Reimbursement Program. The scope was expanded to address system drug funding sustainability. Every jurisdiction around the world grapples with this issue, largely because of increases in individual cancer drug prices over recent years.

Objectives

Identify and review the critical success factors of a sustainable drug reimbursement program.

Recommend a core set of strategic directions and improvements to:

maximize the effectiveness of cancer drug use

support overall system sustainability in a patient-centred way

Outcome

Development of pan-Canadian approaches to prioritization and real-world evidence

Program Information

Ontario Cancer Plan 2015 – 2019 (2014)

Participants

International, provincial and internal expertise in the areas of patient experience and quality of life, sustainability, effectiveness, safety, transitions of care and equity

Summary

Presentations by experts from the United Kingdom, Australia, the United States and Ontario about best practices in their jurisdictions

Review and validation of the strategic objectives of the draft Ontario Cancer Plan 2015 – 2019

Discussion of considerations for implementing initiatives to meet the cancer plan goals

Objectives

Review and validate the strategic priorities of the draft Ontario Cancer Plan 2015 – 2019 based on international, local and internal expertise.

Provide recommendations to Cancer Care Ontario on the Ontario Cancer Plan 2015 – 2019 initiatives and considerations for implementation to ensure the cancer plan encompasses leading practices and addresses the dimension of quality

Disclaimer:The information on this website is intended for informational purposes only and is not a substitute for medical advice. Always consult your healthcare provider if you have questions or concerns. The use of the information on this website does not create a physician-patient relationship between Cancer Care Ontario and you.